Pre-conception Risk Assessment: Medical Problems
This chapter aims to summarise the general principles of pre conception risk assessment for medical disorders in women presenting for fertility treatment in terms of benefits, scope, purpose and logistics. It discusses the specific risks as a consequence of the medical disorder to the pregnancy and effects of the pregnancy on the medical disorder. It also discusses the modifications that may be needed to the ART procedure in common medical disorders. Finally it explores evidence for effectiveness of pre conception risk assessment in terms of measurable effects.
KeywordsART Pre conception Risk assessment Medical disorders
- 1.ART Factsheet. European Society of Human Reproduction and Embryology (ESHRE). 2014. http://www.eshre.eu/Guidelines-and-Legal/ART-fact-sheet.aspx.
- 2.Long term trends in fertility treatment. Human Fertilisation and Embryology Authority (HFEA). 2011. http://www.hfea.gov.uk/2585.html.
- 3.Obesity facts and figures World Health Organisation Fact sheet N°311. European Association for the Study of Obesity (EASO). http://easo.org/obesity-facts-figures.
- 4.RCOG release: Alcohol in pregnancy: information for you. The Royal College of Obstetricians and Gynecologists; 2015.Google Scholar
- 5.Diabetes in pregnancy. NICE clinical guideline No. 63. Issued March 2008, modified December 2014. http://www.nice.org.uk/guidance/cg63.
- 8.Caritis S, Sibai B, Hauth J, Lindheimer MD, Klebanoff M, Thom E, VanDorsten P, Landon M, Paul R, Miodovnik M, Meis P, Thurnau G. Low-dose aspirin to prevent preeclampsia in women at high risk. National Institute of Child Health and Human Development Network of Maternal-Fetal Medicine Units. N Engl J Med. 1998;338(11):701–5.CrossRefPubMedGoogle Scholar
- 10.Pre-conception: advice and management. In Clinical Knowledge summaries. National Institute for Health and Care Excellence. Last revised 2015. http://cks.nice.org.uk/pre-conception-advice-and-management.
- 12.Hypertension in pregnancy: the management of hypertensive disorders during pregnancy. NICE clinical guideline CG 107. 2010.Google Scholar
- 13.Cardiac disease and pregnancy. Good practice No 13. Royal College of Obstetricians and Gynaecologists. June 2011.Google Scholar
- 18.Bromley R, Weston J, Adab N, Greenhalgh J, Sanniti A, McKay AJ, Tudur Smith C, Marson AG. Treatment for epilepsy in pregnancy: neurodevelopmental outcomes in the child. Cochrane Database Syst Rev. 2014;10, CD010236.Google Scholar
- 19.Costedoat-Chalumeau N, Amoura Z, Villain E, Cohen L, Piette JC. Anti-SSA/Ro antibodies and the heart: more than complete congenital heart block? A review of electrocardiographic and myocardial abnormalities and of treatment options. Arthritis Res Ther. 2005;7(2):69–73.CrossRefPubMedPubMedCentralGoogle Scholar
- 21.Reducing the risk of thrombosis and embolism during pregnancy and puerperium. Green top guideline N. 37a. RCOG, Nov 2009.Google Scholar
- 22.Schaefer C, Peters P, Miller RK, editors. Drugs during pregnancy and lactation: treatment options and risk assessment. 2nd ed. Oxford: Academic; 2007.Google Scholar
- 23.The management of ovarian hyperstimulation syndrome Green top guideline No. 5. RCOG Sept 2006.Google Scholar
- 25.De-Regil LM, Fernández-Gaxiola AC, Dowswell T, Peña-Rosas JP. Effects and safety of periconceptional folate supplementation for preventing birth defects. Cochrane Database Syst Rev. 2010;10, CD007950.Google Scholar
- 26.Winterbottom JB, Smyth RM, Jacoby A, Baker GA. Preconception counselling for women with epilepsy to reduce adverse pregnancy outcome. Cochrane Database Syst Rev. 2008;3, CD006645.Google Scholar